Shanghai Junshi Biosciences Co.,Ltd. Posted 1.6 Billion Yuan Net Loss in First Three Quarters of 2023

Shanghai Junshi Biosciences Co.,Ltd. (上海君实生物医药科技股份有限公司) (688180.SH) reported a net loss of 1.6 billion yuan in the first three quarters of 2023, narrowing 10.3% year-on-year.

Meanwhile, the company posted 1 billion yuan in revenue, down 19% year-on-year.

At the end of the reporting period, it had 11.6 billion yuan in total assets and 3.2 billion yuan in total liabilities, with a liability-to-asset ratio of 28%.